Use of Letermovir for Primary and Secondary Cytomegalovirus Prophylaxis in Abdominal Organ Transplantation: A Single Center Experience.
Dima IbrahimJennifer ByrnsEileen K MaziarzBarbara D AlexanderJennifer L SaulloPublished in: Journal of pharmacy practice (2023)
Although letermovir was generally well tolerated, the high rate of failure when used as secondary prophylaxis was noteworthy. Additional controlled clinical trials assessing the safety and efficacy of letermovir prophylaxis in SOT recipients are warranted.